Sandostatin and gait disturbance 
Sandostatin and gait disturbance Patient Reports February 11, 2012
Sandostatin Side Effects Report #5874504-9
Sandostatin side effect was reported by a Consumer or non-health professional from CANADA on Aug 28, 2008. Female patient was diagnosed with neuroendocrine tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: asthenia, decreased appetite, fall
, gait disturbance. Sandostatin dosage: 30 MG, ONCE A MONTH. Patient was hospitalized. Patient recovered.Sandostatin Side Effects Report #5883606-2
Sandostatin side effect was reported by a Consumer or non-health professional from CANADA on Sept 08, 2008. Female patient was diagnosed with neuroendocrine tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: asthenia, blood pressure decreased, decreased appetite, fall
, gait disturbance. Sandostatin dosage: 30 MG, ONCE A MONTH. Patient was hospitalized. Patient recovered.Sandostatin Side Effects Report #5931966-6
Sandostatin side effect was reported by a Consumer or non-health professional from CANADA on Oct 23, 2008. Female patient was diagnosed with neuroendocrine tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: asthenia, blood pressure decreased, cardiac disorder, complication of device insertion, decreased appetite, fall
, gait disturbance, infection , surgery . Sandostatin dosage: 30 MG, ONCE A MONTH. Patient was hospitalized. Patient died on 10/14/2008.Sandostatin Side Effects Report #6075790-5
Sandostatin side effect was reported by a Health Professional from CANADA on Feb 04, 2009. Female patient was diagnosed with gastrinoma and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: flank pain, gait disturbance, heart rate increased, hypotension, injection site pain, localised oedema, musculoskeletal pain, oedema peripheral. Sandostatin dosage: 30 MG EVERY 4 WEEKS. During the same period patient was treated with SANDOSTATIN LAR. Patient was hospitalized. Patient recovered.
Sandostatin Side Effects Report #6121634-2
Sandostatin side effect was reported by a Health Professional from CANADA on Mar 10, 2009. Female patient was diagnosed with gastrinoma and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: flank pain, gait disturbance, heart rate increased, hypotension, injection site pain, localised oedema, musculoskeletal pain, oedema peripheral. Sandostatin dosage: 30 MG EVERY 4 WEEKS. During the same period patient was treated with SANDOSTATIN LAR. Patient was hospitalized. Patient recovered.
Sandostatin Side Effects Report #5890515-1
Sandostatin side effect was reported by a Health Professional from CANADA on Sept 11, 2008. Female patient was diagnosed with carcinoid tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: abdominal cavity drainage, ascites, asthenia, confusional state, diarrhoea, dysstasia, gait disturbance, injection site pain, neoplasm progression. Sandostatin dosage: 30 MG, QMO. During the same period patient was treated with SANDOSTATIN LAR. Patient recovered.
Sandostatin Side Effects Report #5907278-3
Sandostatin side effect was reported by a Health Professional from CANADA on Sept 29, 2008. Female patient was diagnosed with carcinoid tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: abdominal cavity drainage, ascites, asthenia, confusional state, diarrhoea, dysstasia, gait disturbance, injection site pain. Sandostatin dosage: 30 MG, QMO. During the same period patient was treated with SANDOSTATIN LAR. Patient died on 09/22/2008.
Sandostatin Side Effects Report #5353442-4
Sandostatin side effect was reported by a Consumer or non-health professional from UNITED STATES on May 31, 2007. Male patient, 78 years of age, was diagnosed with carcinoid syndrome and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: back pain
, gait disturbance, muscular weakness, parkinsonism. Sandostatin dosage: unknown. Patient recovered.Sandostatin Side Effects Report #5043967-3
Sandostatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2006. Female patient, 76 years of age, weighting 136.0 lb, was diagnosed with carcinoid syndrome, hypothyroidism, hypertension, metastases to bone and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood creatinine increased, blood urea increased, fall
, gait disturbance, hypokalaemia, hyponatraemia, muscular weakness, nuclear magnetic resonance imaging abnormal. Sandostatin dosage: 60 MG, QMO. During the same period patient was treated with SANDOSTATIN LAR, SANDOSTATIN LAR, SYNTHROID, PREVACID, TOPROL, VICOPROFEN, ZOMETA, INTERFERON. Patient was hospitalized. Patient recovered.Sandostatin Side Effects Report #4967228-3
Sandostatin side effect was reported by a Health Professional from UNITED STATES on Mar 29, 2006. Female patient, 76 years of age, was diagnosed with carcinoid syndrome and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: gait disturbance, muscular weakness, oedema peripheral. Sandostatin dosage: 60 MG, QMO. Patient was hospitalized. Patient recovered.
Sandostatin Side Effects Report #4971724-2
Sandostatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2006. Female patient, 76 years of age, weighting 136.0 lb, was diagnosed with carcinoid syndrome, hypothyroidism, hypertension, metastases to bone and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood creatinine increased, blood urea increased, fall
, gait disturbance, hypokalaemia, hyponatraemia, muscular weakness, nuclear magnetic resonance imaging abnormal. Sandostatin dosage: 60 MG, QMO. During the same period patient was treated with SANDOSTATIN LAR, SANDOSTATIN LAR, SYNTHROID, PREVACID, TOPROL, VICOPROFEN, ZOMETA, INTERFERON. Patient was hospitalized. Patient recovered.Sandostatin Side Effects Report #5682310-3
Sandostatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2008. Male patient, 55 years of age, was diagnosed with carcinoid syndrome and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: gait disturbance, hiatus hernia, hypotonia, inflammation, inguinal hernia, metastases to liver, metastases to pancreas, metastases to small intestine, oedema peripheral. Sandostatin dosage: unknown. Patient recovered.
Sandostatin Side Effects Report #5699677-2
Sandostatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 02, 2008. Male patient, 55 years of age, was diagnosed with carcinoid syndrome and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: gait disturbance, hiatus hernia, hypotonia, inflammation, inguinal hernia, metastases to liver, metastases to pancreas, metastases to small intestine, oedema peripheral. Sandostatin dosage: unknown. Patient recovered.
Sandostatin Side Effects Report #5745023-5
Sandostatin side effect was reported by a Consumer or non-health professional from UNITED STATES on May 12, 2008. Male patient, 55 years of age, was diagnosed with carcinoid syndrome and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: gait disturbance, hiatus hernia, hypotonia, inflammation, inguinal hernia, metastases to liver, metastases to pancreas, metastases to small intestine, oedema peripheral. Sandostatin dosage: unknown. Patient recovered.
Sandostatin Side Effects Report #4811402-3
Sandostatin side effect was reported by a Consumer or non-health professional from JAPAN on Nov 15, 2004. Female patient, 60 years of age, was diagnosed with acromegaly and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: diabetic ketoacidosis, gait disturbance, hyperglycaemia. Sandostatin dosage: 20 MG, QMO. During the same period patient was treated with SANDOSTATIN LAR, SANDOSTATIN LAR. Patient was hospitalized. Patient recovered.
Sandostatin Side Effects Report #6137238-1
Sandostatin side effect was reported by a Health Professional from CANADA on Mar 26, 2009. Male patient was diagnosed with acromegaly and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: aphasia
, arrhythmia , cardiac discomfort, cardiac failure, dyspnoea, dyspnoea paroxysmal nocturnal, gait disturbance, loss of consciousness. Sandostatin dosage: 40 MG, QMO. During the same period patient was treated with BROMOCRIPTINE MESYLATE, LANOXIN, FUROSEMIDE, ALTACE, SOTALOL HYDROCHLORIDE, ASPIRIN, SIMVASTATIN. Patient was hospitalized. Patient recovered.Sandostatin Side Effects Report #5920314-3
Sandostatin side effect was reported by a Physician from JAPAN on Oct 07, 2008. Male patient, weighting 176.4 lb, was diagnosed with diabetes mellitus and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, blood alkaline phosphatase increased, blood glucose increased, chest discomfort, constipation , flatulence, gait disturbance, insulin-like growth factor decreased. Sandostatin dosage: unknown. During the same period patient was treated with SANDOSTATIN LAR, MELBIN, BASEN, AMARYL. Patient was hospitalized. Patient recovered.